Biopharma Companies See Direct Sales Success in Asia... 5% Range Annual Rates, Same-Day Refinancing of Margin Loans and Unsettled Trades Possible
As direct sales of biopharmaceuticals gain traction in Asian markets, attention is also turning to the growth potential of follow-on products. There is hope that sales networks established through partnerships with local healthcare institutions and a stable supply can support new products as they enter the market. However, whether expanded sales translate into higher profits depends on the costs of expanding the sales force as well as the profitability of each product.
Investors using margin loans or unsettled trades should consider not only company performance but also the financing costs they will incur over their expected holding period. To adjust the interest burden on existing trades, they can compare the rates, fees, early repayment terms and loan periods of stock-loan refinancing products. By weighing the total costs before and after refinancing and reviewing terms that fit their repayment capacity, they can better manage both their holding plans and their funds.
Meanwhile, interest in stock loans is growing by the day. Investors looking to avoid missing investment opportunities are turning to stock loans, which allow them to access more funds to buy shares.
Another advantage of stock loans is that even if a sharp drop in share prices puts investors using unsettled trades or margin loans at risk of forced liquidation, they can switch to a stock loan through a simple process without providing additional collateral or selling shares, then wait for a rebound.
All New Stock Loan Launches a Product with the Industry's Lowest Annual Interest Rates in the 5% Range!
All New Stock Loan has launched a securities-linked credit product with annual interest rates in the 5% range, among the lowest in the industry, so investors can use stock loans without undue burden. The product can be used both to buy shares and to refinance unsettled trades or margin loans from securities firms. Investors can borrow up to four times their own capital, with no differences in terms based on credit rating. Investors who use alternative trading systems (NXT) can also use the product. Recently, securities firms have shortened the maturity of new margin loans from 180 days to 90 days, so investors concerned about the length of time they can access funds may also want to consider refinancing through a stock loan.
Investors who would like to learn more about All New Stock Loan can contact its customer service center at 1599-8666 to speak with a professional adviser at any time, regardless of whether they qualify for a loan.
- Product with the industry's lowest annual interest rates in the 5% range!
- ETF trading available
- Access to up to four times your capital for share purchases! (Including your own funds)
- Same-day refinancing of securities margin loans and unsettled trades!
- Trading through alternative trading systems (NXT) available
- OK even for shares that were difficult to buy using a securities firm's margin loan or a stock loan!
* All New Stock Loan Customer Service Center: 1599-8666
Visit: https://allnewstockloan.co.kr
Samsung Electronics Preferred, HYBE, Korea Cosmetics Manufacturing, Celltrion, SIMMTECH
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
※ This content does not reflect the editorial policy of The Asia Business Daily. All responsibility rests with the information provider.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.